| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5826378 | Current Opinion in Pharmacology | 2013 | 8 Pages |
Abstract
⺠The role of CAs in current clinical guidelines is discussed. ⺠Clinical trials with CV outcome and meta-analyses support CA usage in CAD. ⺠CAs are effective in overall management of CV risk factors and disease states. ⺠CAs have pleiotropic effects that are useful in managing CAD.
Related Topics
Life Sciences
Neuroscience
Cellular and Molecular Neuroscience
Authors
Rhonda M Cooper-DeHoff, Shin-Wen Chang, Carl J Pepine,